Adamed Pharma S.A., Synhon s.r.o., Synthon Hispania S.L.

The medicinal product is used in the treatment of multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and in the treatment of mantle cell lymphoma (a type of cancer affecting the lymph nodes).

Dosage form: powder for preparation of injection solution

ATC: L01XX32